Vaishali Pharma Limited (NSE:VAISHALI)
8.21
-0.20 (-2.38%)
Aug 19, 2026, 3:28 PM IST
Vaishali Pharma Revenue
Vaishali Pharma had revenue of 234.71M INR in the quarter ending June 30, 2026, a decrease of -1.16%. This brings the company's revenue in the last twelve months to 1.08B, up 3.63% year-over-year. In the fiscal year ending March 31, 2026, Vaishali Pharma had annual revenue of 1.09B with 9.84% growth.
Revenue (ttm)
1.08B
Revenue Growth
+3.63%
P/S Ratio
0.99
Revenue / Employee
40.18M
Employees
27
Market Cap
1.08B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.09B | 97.47M | 9.84% |
| Mar 31, 2025 | 990.26M | 127.46M | 14.77% |
| Mar 31, 2024 | 862.80M | 166.17M | 23.85% |
| Mar 31, 2023 | 696.63M | -61.58M | -8.12% |
| Mar 31, 2022 | 758.21M | 220.47M | 41.00% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sigachi Industries | 4.76B |
| Valiant Laboratories | 3.06B |
| Jagsonpal Pharmaceuticals | 2.94B |
| Balaxi Pharmaceuticals | 2.80B |
| Bafna Pharmaceuticals | 1.43B |
| Par Drugs and Chemicals | 1.09B |
| Alpa Laboratories | 1.04B |
| Brooks Laboratories | 831.47M |
Vaishali Pharma News
- 5 days ago - Vaishali Pharma Quarterly report: Q1 2027 - Filings
- 2 months ago - Vaishali Pharma Quarterly report: Q4 2026 - Filings
- 6 months ago - Vaishali Pharma Quarterly report: Q3 2026 - Filings
- 9 months ago - Vaishali Pharma Quarterly report: Q2 2026 - Filings
- 2 years ago - Vaishali Pharma shares surge 3% after company plans on ambitious growth strategy - Business Upturn
- 2 years ago - Vaishali Pharma to explore merger and acquisition strategy in upcoming board meeting on October 3 - Business Upturn